WHO ICTRP trial
Effects of danshen on the pharmacokinetics of rosuvastatin
JPRN-UMIN000028112 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000028112 |
|---|---|
| Public title | Effects of danshen on the pharmacokinetics of rosuvastatin |
| Scientific title | Effects of danshen on the pharmacokinetics of rosuvastatin - Danshen effects on Pharmacokinetics of rosuvastatin |
| Primary sponsor | Tottori University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | healthy volunteer |
| Interventions | sigle oral dose of rosuvastatin 5 mg with placebo single oral dose of rosuvastatin 5mg with danshen formula 2.5g |
| Registration date | Jun 7, 2017 |
| Target size | 6 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: